Welcome to the Kegonsa Seed Fund Website

Kegonsa Seed Fund I, LP is Wisconsin's premier seed venture capital fund. The Fund is managed by Kegonsa Capital Partners, LLC, a leading Wisconsin venture capital management firm.

On January 15, 2010, the Kegonsa Seed Fund completed its investment period; at this time, the Fund is no longer making investments in new portfolio companies.

For more information about the Kegonsa Seed Fund, please see About the Fund.

Alice.com provides customers with a better way to manage their household essentials online. The Alice service connects customers directly to hundreds of manufacturers for amazing prices. It also allows customers to set up a delivery schedule to receive the items they need, when they need them via always free shipping.

Read the latest news about Alice.com Visit the Alice.com website

Brazen Careerist, Inc. is a career management tool for next-generation professionals. It makes it easy for members to network with each other, express their ideas on issues, and attract potential employers. The company also provides recruitment solutions for companies interested in recruiting Generation Y professionals.

Read the latest news about Brazen Careerist Visit the Brazen Careerist website

Idle Free Systems, Inc. is an innovative provider of the only complete, year-round idle-elimination solutions for trucks. Idle Free's solutions offer drivers and fleet operators a flexible, cost-effective alternative to discretionary idling without compromising performance, cost savings, driver comfort, or environmental safety.

Read the latest news about Idle Free Systems Visit the Idle Free Systems website

Intelligent Bio-Systems, Inc. is developing a next-generation DNA sequencing system that increases the speed and reduces the cost of producing sequence data. By making it easier and less expensive to sequence DNA, IBS's technology has the potential to dramatically change the way research is performed and health care is delivered.

Read the latest news about Intelligent Bio-Systems Visit the Intelligent Bio-Systems website

Jellyfish, Inc. was a provider of innovative e-commerce services that was acquired by Microsoft in September 2007. This sale, which occurred only 19 months after's Jellyfish received its initial seed investment from the Kegonsa Seed Fund, delivered investors a 15 times return, or an annual rate of return over 500 percent.

Medical Cyberworlds, Inc. is an ongoing business. The Kegonsa Seed Fund is no longer a shareholder of Medical Cyberworlds, nor is the Fund involved in the company's operations in any manner at this time. The Kegonsa Seed Fund exited its investment in Medical Cyberworlds via a stock redemption.

NanoMedex Pharmaceuticals, Inc. uses patented strategies to reformulate fat- or lipid-soluble drugs so they can be dissolved in water and administrated intravenously. Drugs reformulated in this way offer a variety of benefits to patients, physicians, and health care providers. NanoMedex's first product is MicrofolTM, a new formulation of propofol, a widely-used anesthetic.

Read the latest news about NanoMedex Pharmaceuticals Visit the NanoMedex website

Read the latest news about Networked Insights Visit the Networked Insights website

NewTunes was an online music retailer that used an innovative search process (indexing songs by sounds) to help users find music through sound relationships. The goal was to create a natural path to increased music sales. NewTunes received its initial capitalization from Kegonsa Seed Fund. The company was dissolved in July 2009.

Praesto, Inc. was developing a home patient-monitoring device (a multiplexor) that would enable the transmission of a patient's health data from their home directly into their healthcare providers' electronic medical record (EMR). Praesto, Inc. received its initial capitalization from Kegonsa Seed Fund. The company was dissolved in August 2007.

Semba Biosciences, Inc. is a biotechnology company that markets the Octave Chromatography System, a highly scalable, cost-effective, desktop-deployable simulated moving bed chromatography (SMBC) system. Semba also sells related SMBC consumables to both Octave customers and third parties.

Read the latest news about Semba Biosciences Visit the Semba Biosciences website

Stealth Therapeutics, Inc. is developing the first micro-invasive intravenous port products. These products minimize scarring and discomfort for patients, especially those requiring months of drug treatment for cancer. Stealth's innovative ports are also easier for physicians to implant and more cost-effective for health care providers.

Read the latest news about Stealth Therapeutics Visit the Stealth Therapeutics website

U.S. Trailmaps, Inc. is a leading provider of GIS-derived map data for recreational trail activities. The company also develops social media communities of map users. U.S. Trailmaps provides mapping data to leading GPS-device manufacturers. The company also provides data for map and smart phone application developers and co-develops related social media sites.

Read the latest news about U.S. Trailmaps Visit the U.S. Trailmaps website

The Kegonsa Seed Fund has invested in thirteen startup companies. One company was acquired, one company completed a stock redemption repurchasing Kegonsa's stock, and nine companies are ongoing. Two investments have failed and the companies have been dissolved.

About Kegonsa Capital Partners

Kegonsa Capital Partners, LLC is a leading Wisconsin venture capital management firm. It is the general partner of the Kegonsa Seed Fund I, LP and the Kegonsa Coinvest Fund, LLC, a growth stage investment fund.

The key investment criteria for Kegonsa Capital Partners are the experience of the entrepreneur and their passion for the company's product.

Welcome to the Kegonsa Seed Fund Website

About Kegonsa Capital Partners

Fund News

Company News